SCHEMBL6284441

SCHEMBL6284441

CCOC(=O)c1cn(CC)c2occc2c1=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.56
TDP1 Q9NUW8 1/20 0.55
ALDH1A1 P00352 6/20 0.48
KDM4E B2RXH2 4/20 0.48
HTT P42858 2/20 0.48
CYP1A2 P05177 1/20 0.48
POLB P06746 2/20 0.47
MAOB P27338 1/20 0.47
HPGD P15428 4/20 0.47
HSD17B10 Q99714 2/20 0.47
SMN1; SMN2 Q16637 3/20 0.46
KMT2A Q03164 3/20 0.45
MEN1 O00255 2/20 0.45
MAPT P10636 2/20 0.45
THRB P10828 1/20 0.45
TSHR P16473 2/20 0.45
MAPK1 P28482 2/20 0.45
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
RXFP1 Q9HBX9 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6282379 0.90 LMNA (0.48) LMNATDP1ALDH1A1KDM4EHTT
SCHEMBL6281429 0.85 MAOB (0.48) LMNATDP1ALDH1A1KDM4EHTT
SCHEMBL6278291 0.85 LMNA (0.47) LMNATDP1ALDH1A1KDM4EHTT
SCHEMBL6282519 0.84 TSHR (0.48) LMNATDP1ALDH1A1KDM4EMAOB
SCHEMBL6281174 0.80 MAOB (0.49) LMNATDP1ALDH1A1KDM4EPOLB
SCHEMBL6285810 0.80 ADRB2 (0.45) LMNATDP1ALDH1A1KDM4EMAOB
SCHEMBL6281585 0.76 HPGD (0.47) LMNATDP1ALDH1A1KDM4EHTT
SCHEMBL11348480 0.76 SMN1; SMN2 (0.51) LMNATDP1ALDH1A1KDM4EHTT
SCHEMBL7056985 0.76 LMNA (0.69) LMNATDP1ALDH1A1KDM4EHTT
SCHEMBL7283936 0.74 TDP1 (0.68) LMNATDP1ALDH1A1KDM4EHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6855771-B2 Process for making block polymers or copolymers from isotactic polypropylene LIGHTHOUSE INTERNATIONAL TECHNOLOGY EXCHANGE LLC (KN) 2005-02-15 US claimed
US-6878705-B2 4-oxo-4,7-dihydrofuro[2,3-b]pyridine-5-carboxamide antiviral agents PFIZER (US) 2005-04-12 US disclosed
US-20040259907-A1 4-OXO-4,7-DIHYDROFURO[2,3-B]PYRIDINE-5-CARBOXAMIDE ANTIVIRAL AGENTS PHARMACIA & UPJOHN COMPANY 2004-12-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259907-A1 4-OXO-4,7-DIHYDROFURO[2,3-B]PYRIDINE-5-CARBOXAMIDE ANTIVIRAL AGENTS IL4, ZC3HAV1, IRF3 LMNA 4193/4885TDP1 1612/4885ALDH1A1 1363/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.